Cargando…
Metformin ameliorates the severity of experimental Alport syndrome
Metformin is widely used for the treatment of type 2 diabetes, and increasing numbers of studies have shown that metformin also ameliorates tumor progression, inflammatory disease, and fibrosis. However, the ability of metformin to improve non-diabetic glomerular disease and chronic kidney disease (...
Autores principales: | Omachi, Kohei, Kaseda, Shota, Yokota, Tsubasa, Kamura, Misato, Teramoto, Keisuke, Kuwazuru, Jun, Kojima, Haruka, Nohara, Hirofumi, Koyama, Kosuke, Ohtsuki, Sumio, Misumi, Shogo, Takeo, Toru, Nakagata, Naomi, Li, Jian-Dong, Shuto, Tsuyoshi, Suico, Mary Ann, Miner, Jeffrey H., Kai, Hirofumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007696/ https://www.ncbi.nlm.nih.gov/pubmed/33782421 http://dx.doi.org/10.1038/s41598-021-86109-1 |
Ejemplares similares
-
Bromide supplementation exacerbated the renal dysfunction, injury and fibrosis in a mouse model of Alport syndrome
por: Yokota, Tsubasa, et al.
Publicado: (2017) -
Trimerization and Genotype–Phenotype Correlation of COL4A5 Mutants in Alport Syndrome
por: Kamura, Misato, et al.
Publicado: (2020) -
CyclosporinA Derivative as Therapeutic Candidate for Alport Syndrome by Inducing Mutant Type IV Collagen Secretion
por: Kuwazuru, Jun, et al.
Publicado: (2023) -
The role of discoidin domain receptor 2 in the renal dysfunction of alport syndrome mouse model
por: Sannomiya, Yuya, et al.
Publicado: (2021) -
Mild electrical stimulation with heat shock attenuates renal pathology in adriamycin-induced nephrotic syndrome mouse model
por: Teramoto, Keisuke, et al.
Publicado: (2020)